SPPI Annual FCF
-$97.26 M
+$22.45 M+18.75%
31 December 2022
Summary:
As of February 5, 2025, SPPI annual free cash flow is -$97.26 million, with the most recent change of +$22.45 million (+18.75%) on December 31, 2022. During the last 3 years, it has risen by +$46.39 million (+32.29%).SPPI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI Quarterly FCF
-$21.55 M
+$4.02 M+15.72%
31 March 2023
Summary:
As of February 5, 2025, SPPI quarterly free cash flow is -$21.55 million, with the most recent change of +$4.02 million (+15.72%) on March 31, 2023. Over the past year, it has increased by +$8.79 million (+28.97%).SPPI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI TTM FCF
-$88.47 M
+$8.79 M+9.03%
31 March 2023
Summary:
As of February 5, 2025, SPPI TTM free cash flow is -$88.47 million, with the most recent change of +$8.79 million (+9.03%) on March 31, 2023. Over the past year, it has increased by +$27.00 million (+23.38%).SPPI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +18.8% | +29.0% | +23.4% |
3 y3 years | +32.3% | +38.0% | +35.9% |
5 y5 years | -147.4% | +19.6% | +38.4% |
SPPI Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -310.5% | -175.7% | -202.7% |
Spectrum Pharmaceuticals Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | -$21.55 M(-15.7%) | -$88.47 M(-9.0%) |
Dec 2022 | -$97.26 M(-18.7%) | -$25.57 M(+42.8%) | -$97.26 M(-4.8%) |
Sept 2022 | - | -$17.91 M(-23.6%) | -$102.12 M(-6.5%) |
June 2022 | - | -$23.45 M(-22.7%) | -$109.21 M(-5.4%) |
Mar 2022 | - | -$30.34 M(-0.3%) | -$115.48 M(-3.5%) |
Dec 2021 | -$119.71 M(-5.9%) | -$30.43 M(+21.7%) | -$119.71 M(-1.2%) |
Sept 2021 | - | -$25.00 M(-15.9%) | -$121.13 M(-4.6%) |
June 2021 | - | -$29.72 M(-14.0%) | -$126.99 M(-0.0%) |
Mar 2021 | - | -$34.56 M(+8.5%) | -$126.99 M(-0.1%) |
Dec 2020 | -$127.16 M(-11.5%) | -$31.85 M(+3.2%) | -$127.16 M(+0.2%) |
Sept 2020 | - | -$30.86 M(+3.8%) | -$126.86 M(-2.8%) |
June 2020 | - | -$29.72 M(-14.4%) | -$130.52 M(-5.4%) |
Mar 2020 | - | -$34.74 M(+10.1%) | -$138.02 M(-3.9%) |
Dec 2019 | -$143.65 M(+120.5%) | -$31.54 M(-8.6%) | -$143.65 M(+13.0%) |
Sept 2019 | - | -$34.52 M(-7.3%) | -$127.13 M(+22.9%) |
June 2019 | - | -$37.22 M(-7.8%) | -$103.46 M(+31.4%) |
Mar 2019 | - | -$40.37 M(+168.8%) | -$78.73 M(+20.8%) |
Dec 2018 | -$65.16 M(+65.7%) | -$15.02 M(+38.5%) | -$65.16 M(+3.3%) |
Sept 2018 | - | -$10.85 M(-13.2%) | -$63.09 M(+6.9%) |
June 2018 | - | -$12.50 M(-53.4%) | -$58.99 M(+28.7%) |
Mar 2018 | - | -$26.80 M(+106.9%) | -$45.85 M(+16.6%) |
Dec 2017 | -$39.32 M(-3.0%) | -$12.95 M(+91.9%) | -$39.32 M(+32.2%) |
Sept 2017 | - | -$6.75 M(-1151.1%) | -$29.75 M(-17.3%) |
June 2017 | - | $642.00 K(-103.2%) | -$35.95 M(-33.0%) |
Mar 2017 | - | -$20.26 M(+499.1%) | -$53.66 M(+32.4%) |
Dec 2016 | -$40.54 M(-721.6%) | -$3.38 M(-73.9%) | -$40.54 M(+19.0%) |
Sept 2016 | - | -$12.95 M(-24.1%) | -$34.06 M(+11.8%) |
June 2016 | - | -$17.06 M(+138.8%) | -$30.46 M(-742.3%) |
Mar 2016 | - | -$7.14 M(-331.2%) | $4.74 M(-27.3%) |
Dec 2015 | $6.52 M(-243.0%) | $3.09 M(-133.1%) | $6.52 M(-54.5%) |
Sept 2015 | - | -$9.35 M(-151.5%) | $14.32 M(-56.8%) |
June 2015 | - | $18.14 M(-438.1%) | $33.15 M(+9.1%) |
Mar 2015 | - | -$5.37 M(-149.3%) | $30.38 M(-766.1%) |
Dec 2014 | -$4.56 M(+103.0%) | $10.89 M(+14.8%) | -$4.56 M(-0.1%) |
Sept 2014 | - | $9.48 M(-38.3%) | -$4.57 M(-83.4%) |
June 2014 | - | $15.37 M(-138.1%) | -$27.50 M(-57.1%) |
Mar 2014 | - | -$40.31 M(-470.3%) | -$64.16 M(+2755.1%) |
Dec 2013 | -$2.25 M(-104.9%) | $10.89 M(-180.9%) | -$2.25 M(-55.5%) |
Sept 2013 | - | -$13.45 M(-36.8%) | -$5.04 M(-118.5%) |
June 2013 | - | -$21.28 M(-198.5%) | $27.32 M(-33.4%) |
Mar 2013 | - | $21.60 M(+167.0%) | $41.00 M(-11.3%) |
Dec 2012 | $46.21 M(+7.9%) | $8.09 M(-57.2%) | $46.21 M(-5.7%) |
Sept 2012 | - | $18.91 M(-348.8%) | $48.99 M(-2.2%) |
June 2012 | - | -$7.60 M(-128.4%) | $50.07 M(-41.9%) |
Mar 2012 | - | $26.81 M(+146.7%) | $86.16 M(+101.2%) |
Dec 2011 | $42.81 M(-277.5%) | $10.87 M(-45.6%) | $42.81 M(+1.8%) |
Sept 2011 | - | $19.99 M(-29.8%) | $42.04 M(+120.5%) |
June 2011 | - | $28.48 M(-272.3%) | $19.07 M(-233.0%) |
Mar 2011 | - | -$16.53 M(-263.7%) | -$14.34 M(-40.5%) |
Dec 2010 | -$24.12 M(+31.8%) | $10.10 M(-438.8%) | -$24.12 M(-46.9%) |
Sept 2010 | - | -$2.98 M(-39.5%) | -$45.43 M(-15.1%) |
June 2010 | - | -$4.93 M(-81.3%) | -$53.49 M(+19.5%) |
Mar 2010 | - | -$26.31 M(+134.6%) | -$44.76 M(+144.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | -$18.31 M(+92.2%) | -$11.21 M(+1.6%) | -$18.31 M(+43.0%) |
Sept 2009 | - | -$11.04 M(-390.3%) | -$12.80 M(+38.7%) |
June 2009 | - | $3.80 M(+2558.7%) | -$9.23 M(+334.2%) |
Mar 2009 | - | $143.00 K(-102.5%) | -$2.13 M(-77.7%) |
Dec 2008 | -$9.52 M(-63.0%) | -$5.71 M(-23.5%) | -$9.52 M(-31.0%) |
Sept 2008 | - | -$7.46 M(-168.4%) | -$13.81 M(+18.6%) |
June 2008 | - | $10.90 M(-250.3%) | -$11.64 M(-57.6%) |
Mar 2008 | - | -$7.25 M(-27.4%) | -$27.44 M(+6.5%) |
Dec 2007 | -$25.76 M(+87.0%) | -$9.99 M(+88.7%) | -$25.76 M(+60.0%) |
Sept 2007 | - | -$5.30 M(+8.2%) | -$16.10 M(+5.7%) |
June 2007 | - | -$4.89 M(-12.3%) | -$15.23 M(-2.4%) |
Mar 2007 | - | -$5.58 M(+1564.8%) | -$15.61 M(+13.3%) |
Dec 2006 | -$13.78 M(-14.9%) | -$335.00 K(-92.4%) | -$13.78 M(-25.1%) |
Sept 2006 | - | -$4.42 M(-16.1%) | -$18.39 M(+3.6%) |
June 2006 | - | -$5.27 M(+40.6%) | -$17.76 M(+6.0%) |
Mar 2006 | - | -$3.75 M(-24.3%) | -$16.75 M(+3.5%) |
Dec 2005 | -$16.18 M(+34.5%) | -$4.95 M(+30.7%) | -$16.18 M(+14.5%) |
Sept 2005 | - | -$3.79 M(-11.1%) | -$14.13 M(+2.9%) |
June 2005 | - | -$4.26 M(+33.7%) | -$13.73 M(+17.1%) |
Mar 2005 | - | -$3.19 M(+10.0%) | -$11.72 M(-2.5%) |
Dec 2004 | -$12.03 M(+81.7%) | -$2.90 M(-14.4%) | -$12.03 M(+18.1%) |
Sept 2004 | - | -$3.39 M(+50.5%) | -$10.19 M(+12.4%) |
June 2004 | - | -$2.25 M(-35.6%) | -$9.06 M(+3.3%) |
Mar 2004 | - | -$3.49 M(+231.4%) | -$8.77 M(+32.4%) |
Dec 2003 | -$6.62 M(-54.5%) | -$1.05 M(-53.4%) | -$6.62 M(+28.3%) |
Sept 2003 | - | -$2.26 M(+15.5%) | -$5.16 M(-21.9%) |
June 2003 | - | -$1.96 M(+45.4%) | -$6.61 M(-28.8%) |
Mar 2003 | - | -$1.35 M(-431.8%) | -$9.28 M(-36.3%) |
Dec 2002 | -$14.56 M(-44.4%) | $405.90 K(-110.9%) | -$14.56 M(-35.2%) |
Sept 2002 | - | -$3.71 M(-19.9%) | -$22.47 M(-11.3%) |
June 2002 | - | -$4.63 M(-30.1%) | -$25.34 M(-7.1%) |
Mar 2002 | - | -$6.62 M(-11.8%) | -$27.29 M(+4.2%) |
Dec 2001 | -$26.19 M(-39.6%) | -$7.51 M(+14.1%) | -$26.19 M(+16.0%) |
Sept 2001 | - | -$6.58 M(-0.0%) | -$22.59 M(-35.8%) |
June 2001 | - | -$6.58 M(+19.0%) | -$35.17 M(-11.6%) |
Mar 2001 | - | -$5.53 M(+41.7%) | -$39.79 M(-8.3%) |
Dec 2000 | -$43.40 M(+114.0%) | -$3.90 M(-79.6%) | -$43.40 M(-7.8%) |
Sept 2000 | - | -$19.16 M(+71.1%) | -$47.08 M(+43.0%) |
June 2000 | - | -$11.20 M(+22.6%) | -$32.91 M(+28.5%) |
Mar 2000 | - | -$9.14 M(+20.6%) | -$25.61 M(+26.3%) |
Dec 1999 | -$20.28 M(+91.3%) | -$7.58 M(+51.5%) | -$20.28 M(+26.7%) |
Sept 1999 | - | -$5.00 M(+28.2%) | -$16.00 M(+15.1%) |
June 1999 | - | -$3.90 M(+2.6%) | -$13.90 M(+16.8%) |
Mar 1999 | - | -$3.80 M(+15.2%) | -$11.90 M(+12.3%) |
Dec 1998 | -$10.60 M(+11.6%) | -$3.30 M(+13.8%) | -$10.60 M(+9.3%) |
Sept 1998 | - | -$2.90 M(+52.6%) | -$9.70 M(-1.0%) |
June 1998 | - | -$1.90 M(-24.0%) | -$9.80 M(+8.9%) |
Mar 1998 | - | -$2.50 M(+4.2%) | -$9.00 M(-5.3%) |
Dec 1997 | -$9.50 M(+630.8%) | -$2.40 M(-20.0%) | -$9.50 M(+33.8%) |
Sept 1997 | - | -$3.00 M(+172.7%) | -$7.10 M(+73.2%) |
June 1997 | - | -$1.10 M(-63.3%) | -$4.10 M(+36.7%) |
Mar 1997 | - | -$3.00 M | -$3.00 M |
Dec 1996 | -$1.30 M | - | - |
FAQ
- What is Spectrum Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals annual FCF year-on-year change?
- What is Spectrum Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals quarterly FCF year-on-year change?
- What is Spectrum Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals TTM FCF year-on-year change?
What is Spectrum Pharmaceuticals annual free cash flow?
The current annual FCF of SPPI is -$97.26 M
What is the all time high annual FCF for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high annual free cash flow is $46.21 M
What is Spectrum Pharmaceuticals annual FCF year-on-year change?
Over the past year, SPPI annual free cash flow has changed by +$22.45 M (+18.75%)
What is Spectrum Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SPPI is -$21.55 M
What is the all time high quarterly FCF for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high quarterly free cash flow is $28.48 M
What is Spectrum Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SPPI quarterly free cash flow has changed by +$8.79 M (+28.97%)
What is Spectrum Pharmaceuticals TTM free cash flow?
The current TTM FCF of SPPI is -$88.47 M
What is the all time high TTM FCF for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high TTM free cash flow is $86.16 M
What is Spectrum Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SPPI TTM free cash flow has changed by +$27.00 M (+23.38%)